Shares of blood products company Haemonetics (NYSE:HAE) jumped 12.4% in the morning session after CSL Plasma announced ...
Haemonetics (HAE) just saw its stock jump more than 13% after CSL Plasma committed to deploy the NexSys PCS devices with ...
Haemonetics Corporation HAE stock surged Thursday after the company disclosed that CSL Plasma Inc. plans to deploy its NexSys ...
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced it has received clearance from the ...
Haemonetics Corporation reported strong fiscal Q1 2024 financial performance, beating estimates for non-GAAP EPS and revenue. The company's advancements in the NexSys Plasma collection system and ...
Haemonetics HAE recently received FDA clearance for the enhancements to its NexSys PCS plasma collection system. These include a new plasma collection bowl, which features a design that optimizes ...
Haemonetics shares rose more than 15% after CSL Plasma said it expects to install the company's plasma collection systems at all its US centres by the end of 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results